You know that psychedelics are making a comeback when the New York Times says so on page 1. In “Hallucinogens Have Doctors Tuning In,” John Tierney reports on how doctors at schools like Harvard, Johns Hopkins, UCLA and NYU are testing the potential of psilocybin and other hallucinogens for treating depression, obsessive-compulsive disorder, post-traumatic stress disorder, alcoholism—and for inducing spiritual experiences. Tierney’s brisk overview neglects to mention the most mind-bending of all psychedelics: dimethyltryptamine, or DMT...
In recent posts, I’ve knocked neuroframing, neuroweapons and neurobics. Next up: neuro-lit-crit.
New York Times culture reporter Patricia Cohen reports that for insights and inspiration literary scholars are turning, inevitably, to neuroscience and evolutionary psychology...
Of all scientific fields, neuroscience has the greatest potential for revolutionary advances, philosophical and practical. Someday, brain researchers may figure out how precisely the brain encodes thoughts like the ones I’m thinking now...
Last week the Garrison Institute, a retreat center just a few miles down the Hudson River from my home, hosted an impressive symposium on “Climate, Mind and Behavior.” An organizer made the mistake of inviting me to the meeting’s wrap-up session Friday...
